Communiqués

24/08 AZENTA ANNOUNCES LEADERSHIP TRANSITION PR
05/08 Azenta : Press Release (AZTA 2026 Q3 26 ER EX 99 1) PU
04/08 Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026. PR
22/07 Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast PR
14/07 Artisan Industries Appoints Stephen Schwartz and Gary Doyon to Board of Directors AQ
08/07 Azenta Completes Sale of B Medical Systems PR
21/05 Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report PR
06/05 Azenta : Presentation (Q2 26 Earnings Deck FINAL 05 05 26) PU
06/05 Azenta : Press Release (Q2 26 Earnings Release 05 05 26) PU
06/05 Azenta : Supplemental Information (Q2 26 Earnings Supplemental Letter 05 05 26) PU
05/05 Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029 PR
29/04 Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast PR
07/04 Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution PR
04/03 Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities PR
24/02 Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference PR
09/02 Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure PR
04/02 Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 PR
21/01 Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast PR
30/12 Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L. AQ
29/12 Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. PR
10/12 Azenta : 2025 Investor Day Presentation PU
10/12 Azenta Authorizes $250 Million Share Repurchase Program PR
21/11 Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 PR
12/11 Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast PR
04/11 Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer PR
Aucun résultat pour cette recherche
🔇